» Articles » PMID: 38656991

Understanding of Cervical Cancer, Acceptability of HPV Self-collection, and Prevalence of HPV in a Semi-urban Setting in Bangladesh

Overview
Specialty Public Health
Date 2024 Apr 24
PMID 38656991
Authors
Affiliations
Soon will be listed here.
Abstract

Human Papillomavirus (HPV) self-sampling has been implemented successfully as an alternative to traditional forms of cervical cancer screening in low-resource settings. Through Bangladesh's current national cervical cancer screening program, only about 10% of the at-risk population is reached. Thus, Bangladesh is an ideal setting to consider HPV self-sampling to improve cervical cancer prevention efforts. However, the feasibility and acceptability of HPV self-sampling has not been evaluated in Bangladesh. We aimed to understand levels of HPV and cervical cancer knowledge and to evaluate the feasibility and acceptability of HPV self-sampling for cervical cancer screening in a semi-urban Bangladeshi community. Participants were recruited from a local clinic; 164 women completed a cross-sectional questionnaire about attitudes towards screening, and cervical cancer and HPV risk factor knowledge, and provided self-collected cervical samples for high-risk HPV testing. Of the participants, 4.3% tested positive for high-risk HPV and were referred for appropriate follow-up care. Nearly all participants had heard of cervical cancer, though specific knowledge was quite low. Self-sampling for high-risk HPV testing had high rates of acceptability, high rates of convenience, and very little discomfort and embarrassment reported in this study population, making implementing HPV self-sampling as a form of cervical cancer screening in Bangladesh appear feasible.

Citing Articles

Overcoming Cultural Barriers and Building Healthcare Trust: A Mixed Methods Study on Cervical Cancer Prevention Among Arab American Women Across Major U.S. Cities.

Khoja L, Zoulfikar M, Hak L, Yousif S, Aljebori M, Stiffler M Cancers (Basel). 2025; 17(1.

PMID: 39796637 PMC: 11718821. DOI: 10.3390/cancers17010005.

References
1.
Abdullah N, Daud S, Wang S, Mahmud Z, Kornain N, Al-Kubaisy W . Human Papilloma Virus (HPV) self-sampling: do women accept it?. J Obstet Gynaecol. 2018; 38(3):402-407. DOI: 10.1080/01443615.2017.1379061. View

2.
Appleby P, Beral V, Berrington de Gonzalez A, Colin D, Franceschi S, Goodhill A . Cervical cancer and hormonal contraceptives: collaborative reanalysis of individual data for 16,573 women with cervical cancer and 35,509 women without cervical cancer from 24 epidemiological studies. Lancet. 2007; 370(9599):1609-21. DOI: 10.1016/S0140-6736(07)61684-5. View

3.
Bosch F, Lorincz A, Munoz N, Meijer C, Shah K . The causal relation between human papillomavirus and cervical cancer. J Clin Pathol. 2002; 55(4):244-65. PMC: 1769629. DOI: 10.1136/jcp.55.4.244. View

4.
Chelimo C, Wouldes T, Cameron L, Elwood J . Risk factors for and prevention of human papillomaviruses (HPV), genital warts and cervical cancer. J Infect. 2012; 66(3):207-17. DOI: 10.1016/j.jinf.2012.10.024. View

5.
Nakalembe M, Makanga P, Kambugu A, Laker-Oketta M, Huchko M, Martin J . A public health approach to cervical cancer screening in Africa through community-based self-administered HPV testing and mobile treatment provision. Cancer Med. 2020; 9(22):8701-8712. PMC: 7666725. DOI: 10.1002/cam4.3468. View